Your browser doesn't support javascript.
loading
A nationwide evaluation of deceased donor kidney transplantation indicates detrimental consequences of early graft loss.
de Kok, Michèle J; Schaapherder, Alexander F; Mensink, Jacobus W; de Vries, Aiko P; Reinders, Marlies E; Konijn, Cynthia; Bemelman, Frederike J; van de Wetering, Jacqueline; van Zuilen, Arjan D; Christiaans, Maarten H; Baas, Marije C; Nurmohamed, Azam S; Berger, Stefan P; Ploeg, Rutger J; Alwayn, Ian P; Lindeman, Jan H.
Afiliação
  • de Kok MJ; Department of Surgery and Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands.
  • Schaapherder AF; Department of Surgery and Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands.
  • Mensink JW; Department of Surgery and Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands; Dutch Transplant Foundation, Leiden, The Netherlands.
  • de Vries AP; Department of Internal Medicine (Nephrology) and Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands.
  • Reinders ME; Department of Internal Medicine (Nephrology) and Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands.
  • Konijn C; Dutch Transplant Foundation, Leiden, The Netherlands.
  • Bemelman FJ; Department of Internal Medicine (Nephrology), Amsterdam UMC, Academic Medical Center, Amsterdam, The Netherlands.
  • van de Wetering J; Department of Internal Medicine (Nephrology), Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van Zuilen AD; Department of Internal Medicine (Nephrology), University Medical Center Utrecht, Utrecht, The Netherlands.
  • Christiaans MH; Department of Internal Medicine (Nephrology), Maastricht University Medical Center, Maastricht, The Netherlands.
  • Baas MC; Department of Internal Medicine (Nephrology), Radboud University Medical Center, Nijmegen, The Netherlands.
  • Nurmohamed AS; Department of Internal Medicine (Nephrology), Amsterdam UMC, VU Medical Center, Amsterdam, The Netherlands.
  • Berger SP; Department of Internal Medicine (Nephrology), University Medical Center Groningen, Groningen, The Netherlands.
  • Ploeg RJ; Department of Surgery and Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
  • Alwayn IP; Department of Surgery and Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands.
  • Lindeman JH; Department of Surgery and Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: lindeman@lumc.nl.
Kidney Int ; 97(6): 1243-1252, 2020 06.
Article em En | MEDLINE | ID: mdl-32359810
ABSTRACT
Early graft loss (EGL) is a feared outcome of kidney transplantation. Consequently, kidneys with an anticipated risk of EGL are declined for transplantation. In the most favorable scenario, with optimal use of available donor kidneys, the donor pool size is balanced by the risk of EGL, with a tradeoff dictated by the consequences of EGL. To gauge the consequence of EGL we systematically evaluated its impact in an observational study that included all 10,307 deceased-donor kidney transplantations performed in The Netherlands between 1990 and 2018. Incidence of EGL, defined as graft loss within 90 days, in primary transplantation was 8.2% (699/8,511). The main causes were graft rejection (30%), primary nonfunction (25%), and thrombosis or infarction (20%). EGL profoundly impacted short- and long-term patient survival (adjusted hazard ratio; 95% confidence interval 8.2; 5.1-13.2 and 1.7; 1.3-2.1, respectively). Of the EGL recipients who survived 90 days after transplantation (617/699) only 440 of the 617 were relisted for re-transplantation. Of those relisted, only 298 were ultimately re-transplanted leading to an actual re-transplantation rate of 43%. Noticeably, re-transplantation was associated with a doubled incidence of EGL, but similar long-term graft survival (adjusted hazard ratio 1.1; 0.6-1.8). Thus, EGL after kidney transplantation is a medical catastrophe with high mortality rates, low relisting rates, and increased risk of recurrent EGL following re-transplantation. This implies that detrimental outcomes also involve convergence of risk factors in recipients with EGL. The 8.2% incidence of EGL minimally impacted population mortality, indicating this incidence is acceptable.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article